A subset of gliomas, those showing IDH1 mutations, are characterized by extensive DNA hypermethylation of CpG islands, a phenomenon referred to as glioma CpG island methylator phenotype (glioma CIMP) [35]. This evidence concerns the gene IDH1 and central nervous system cancer.